AzTrials
AzTrials

Radiculopathy LumbarNCT06275529

Evaluation of Transforaminal Epidural Steroid Injection in Radicular Low Back Pain According to MSU Classification

A study testing Transforaminal Epidural Steroid Injection in people with Radiculopathy Lumbar and Low Back Pain, run by Başakşehir Çam & Sakura City Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Low back pain is a common disease in all ages and it effects seriously quality of life. Medical treatment,interventional methods and surgery are the treatment options. Transforaminal epidural steroid injections (TFSI) is one of the interventional method for radiculopathy with low back pain. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Transforaminal Epidural Steroid Injection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Mar 2024to 15 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • between the ages of 18-65
  • After outpatient evaluation, a decision was made to perform transforaminal steroid injection,
  • Low back pain of more than 6 on a numeric rating scale (NRS)
  • Radiculopathy for more than 4 weeks and less than one year and straight leg raising <45
  • Disc herniation at the L4-L5 or L5-S1 level on MRI
  • Failure to respond to medical treatment for at least one month

Who cannot join

  • Neurological deficit,
  • Bleeding problems,
  • Localized infection,
  • Spinal pathologies (such as tumors),
  • Fractures,
  • Severe stenosis,
Show all 13Show fewer
  • Uncontrolled diabetes,
  • Pregnancy,
  • Red flag symptoms (such as motor and/or sphincter dysfunction)
  • Patient reluctance,
  • Computed tomography (CT) and MRI findings in favor of sequestrated fragments from herniated disc,
  • Sphincteric disorders,
  • Previous spine surgeries

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Başakşehir Çam and Sakura City Hospital

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of Pain and Oswestry Disability Index in Different Types of Disc Herniation According to MSU Classification in Patients Undergoing Transforaminal Epidural Steroid Injection for Radicular Low Back Pain

Low back pain is a common disease in all ages and it effects seriously quality of life. Medical treatment,interventional methods and surgery are the treatment options. Transforaminal epidural steroid injections (TFSI) is one of the interventional method for radiculopathy with low back pain. Michigan State University(MSU) classification is a MRI based disc herniation classification. It helps to classified disc herniation in types, places and sizes.

The aim of this study to evaluate the pain and oswestry disability index in patients who have radiculopathy with low back pain, undergone TFSI according to MSU classification.

Being tested
Transforaminal Epidural Steroid Injection
Medical subject headings
Low Back Pain, Intervertebral Disc Displacement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transforaminal Epidural Steroid InjectionProcedure or surgery

    Epidural injections have been used since about 1900 for the treatment of low back and lower extremity pain, with steroids added to local anesthetics in about 1950. The epidural space can be entered by 3 approaches: caudal, interlaminar, and transforaminal. Transforaminal Epidural Steroid Injections:

    After the patient is monitored in pron position and asepsis is ensured, the epidural space is entered with the appropriate needle through the transforaminal space by giving the necessary angles to the fluoroscopy. Then the location is confirmed with radiopaque agent and steroid injection is performed. The procedure takes 15-20 minutes.

Study groups in NCT06275529
Study groupRoleWhat they receive
MSU Classification 1AExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 1A
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 1BExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 1B
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 1CExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 1C
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 2AExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 2A
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 2BExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 2B
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 2CExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 2C
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 3AExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 3A
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 3BExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 3B
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 2ABExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 2AB
Receives: Procedure: Transforaminal Epidural Steroid Injection
MSU Classification 3ABExperimentalTransforaminal Epidural Steroid Injection, MSU classification according to MRI images 3AB
Receives: Procedure: Transforaminal Epidural Steroid Injection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of the pain severity score

    Pain severity is assessed by using "Numeric Rating Scale" (NRS). Patients give score of their pain between 0 (no pain) and 10 (worst possible pain).

    The change in NRS scores between the ten groups will be compared.

    Measured: Pre-intervention, post-intervention 1th month and post-intervention 3rd month

  2. Change of the disability score

    Disability conditions of the patients are assessed by using "Oswestry Disability Index" (ODI). ODI is a patient completed questionnaire which gives a percentage score of disability. The ODI is comprised of 10 items and enquires about functional limitations in various activities of daily living with the index score ranging from 1 (best) to 100 (worst).

    The change in ODI scores between the ten groups will be compared.

    Measured: Pre-intervention, post-intervention 1th month and post-intervention 3rd month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2024
  2. Study start15 Mar 2024
  3. Primary completion15 Oct 2024
  4. Study completion15 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06275529
Sponsor's protocol ID
27.12.2023.685
Status last verified
Jan 2025
First submitted
17 Feb 2024
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tanyel Saracoglu T, Erken B. Impact of transforaminal epidural steroid injection on pain and disability outcomes by lumbar intervertebral disc herniation class: a prospective study. Pain Med. 2025 Aug 1;26(8):440-450. doi: 10.1093/pm/pnaf040.

    PubMed 40172933

Questions about this trial

What is this clinical trial studying?

A study testing Transforaminal Epidural Steroid Injection in people with Radiculopathy Lumbar and Low Back Pain, run by Başakşehir Çam & Sakura City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of the pain severity score (time frame: Pre-intervention, post-intervention 1th month and post-intervention 3rd month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06275529, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in